(Reuters) – Novo Nordisk has sued one compounding pharmacy and refiled a lawsuit against another after finding their products claiming to contain the active ingredient for its in-demand weight-loss drug Wegovy were impure, some by as much as 33%.
The Danish drugmaker said it found impurities in all the drugs tested from Wells Pharmacy and Brooksville P